Baystate Wealth Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$12.1K Sell
88
-15
-15% -$1.95K ﹤0.01% 683
2023
Q3
$13.4K Buy
103
+42
+69% +$5.58K ﹤0.01% 529
2023
Q2
$8.15K Buy
61
+46
+307% +$6.06K ﹤0.01% 607
2023
Q1
$1.96K Hold
15
﹤0.01% 833
2022
Q4
$2K Buy
+15
New +$1.99K ﹤0.01% 818
2021
Q1
Sell
-40
Closed -$5K 844
2020
Q4
$5K Hold
40
﹤0.01% 501
2020
Q3
$4K Hold
40
﹤0.01% 483
2020
Q2
$4K Buy
+40
New +$3.95K ﹤0.01% 493
2018
Q3
Sell
-169
Closed -$15K 708
2018
Q2
$15K Buy
169
+115
+213% +$9.53K ﹤0.01% 328
2018
Q1
$4K Buy
+54
New +$4.6K ﹤0.01% 457

Other funds holding XLV

Baystate Wealth Management's XLV Position: Q4 2023 in Review

Baystate Wealth Management reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 15% in Q4 2023, selling an estimated $1.95K and leaving 88 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

Baystate Wealth Management first reported a position in XLV in Q1 2018 and has held it in 10 quarters since. The position peaked at $15K in Q2 2018. 1,641 funds tracked by Wall St. Rank hold XLV as of Q4 2023.

  • Baystate Wealth Management held 88 shares of State Street Health Care Select Sector SPDR ETF worth $12.1K as of Q4 2023.
  • Baystate Wealth Management sold 15 State Street Health Care Select Sector SPDR ETF shares in Q4 2023, an estimated $1.95K.
  • State Street Health Care Select Sector SPDR ETF made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #683 holding.
  • Baystate Wealth Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2018 and has held it in 10 quarters since.
  • Baystate Wealth Management's State Street Health Care Select Sector SPDR ETF position peaked at $15K in Q2 2018.
  • 1,641 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.